Other OTC • Healthcare • Biotechnology • US • USD
GlobeImmune, Inc. (GBIM) has a market capitalization of $575.00 and trades at $0.00. The 52-week range is 0.000001-0.0005.
The stock has a beta of -200.46, operates in the Healthcare sector.
Be the first to know when stocks drop below their intrinsic value.
